DeuterOncology is a clinical-stage drug development company. Its lead product, DO-2, is a deuterated MET kinase inhibitor that is brain penetrant and is being developed as a potential ‘best in class’ targeted therapy for MET driven disease. MET-inhibitors shows success in NSCLC however these treatments are hindered by the toxic…
With a Life Sciences pedigree and a passion for shaping a healthier, sustainable and safer world, our 1100+ design, engineering and project delivery experts are proud to support the health and biotech valley of tomorrow initiative across Belgium. Life Sciences & Industry A multi-disciplinary design, engineering and project delivery company,…
Tiamat Sciences is a startup providing high-value biomolecules to companies working in the novel food and pharmaceutical sectors. Thanks to an innovative protein production platform, Tiamat offers the fastest solution on the market for scalable and cost-effective production of animal-free biomolecules. Contact France-Emmanuelle Adil, CEO Naàlia Marinho, Site Leader BE…
NeuVasQ is developing pharmaceutical treatments to restore the blood-brain barrier function in acute neurological disorders such as stroke and epilepsy, and in neurodegenerative disorders like Alzheimer’s disease. Disruptive technology NeuVasQ Biotechnologies, a spin-off from the Université Libre de Bruxelles (ULB), is developing pharmaceuticals to sustain or restore the neurovascular function,…